Patent · US Active

Antibody targeting CD22 and CD79B

US12180278B2 · kind B2 · utility

0Cited by

17References

29Claims

0Family size

Assignee

JANSSEN BIOTECH, INC. · US

Inventors

Kyle J. Bednar · Conshohocken, US
Naresh Kumar · Barwala, IN
Sanjaya Singh · Sandy Hook, US
Danlin Yang · Philadelphia, US
Rajkumar Ganesan · Blue Bell, US

Key dates

Filing date	Mar 23, 2022
Grant date	Dec 31, 2024
Priority date	—
Expiry date	Mar 23, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are multispecific antibodies, that bind to CD79b and CD22, polynucleotides encoding them, vectors, host cells, methods of making and using them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.